Here's How Trump's Pick To Lead The FDA Can Supercharge The Agency

FORBES

The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration.

During his confirmation hearing, Makary said his goals for the agency were "more cures and meaningful treatments for Americans." Throughout the hearing, he offered insight on how he would achieve those goals, including leveraging artificial intelligence and making other regulatory changes to streamline the drug review process.

Read more here.

Previous
Previous

China’s Biotech Advances Threaten U.S. Dominance, Warns Congressional Report

Next
Next

The Pharmaceutical Trade War with Europe Did Not Begin Recently